← Leaderboards
Martin Friedlander
Scripps Research Institute
$49,465,428
Attributed
$49,465,428
Total exposure
6
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $4.6M · FY2005–16$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
Funding mix
By agency
NIH$53,020,708 · 7
By mechanism
R24$37,744,530 · 3
R01$11,720,898 · 2
P30$3,555,280 · 2
Top collaborators
No co-investigators on record.
Most similar at Scripps Research Institute
Same institution · by research overlap
- David A Cheresh$37,188,318
- David D Schlaepfer$17,083,110
Others in their field
Top investigators on “Angiogenesis”
- David Heimbrook · Leidos Biomedical Research, Inc.$75,067,502
- Steven Terry Rosen · Beckman Research Institute/City Of Hope$59,567,306
- Larry Arthur$33,866,306
- Michael Simons · Yale University$30,647,106
- Henry Shelton Earp · Univ Of North Carolina Chapel Hill$29,372,588
- David A Cheresh · Scripps Research Institute$29,095,930
Research focus
AngiogenesisCell TypeNeovascularizationEndothelial CellsRetinalBlood VesselsBlindnessHuman TissueIntegrinsDiabetic RetinopathyExtracellular MatrixOcular AngiogenesisTissuesCellsAstrocytesRetinaRetinal AngiogenesisMouse ModelMolecularEye DiseasesNeovascularBasePathologic NeovascularizationHemorrhage
Grant awards (44)
MicroRNAs for therapy of visual disorders$1,892,520
R24 · FY2016 · EY · contact PI
Integrins and Ocular Angiogenesis$742,895
R01 · FY2016 · EY · contact PI
MicroRNAs for therapy of visual disorders$2,099,016
R24 · FY2015 · EY · contact PI
Integrins and Ocular Angiogenesis$728,038
R01 · FY2015 · EY · contact PI
MicroRNAs for therapy of visual disorders$1,947,581
R24 · FY2014 · EY · contact PI
Integrins and Ocular Angiogenesis$734,251
R01 · FY2014 · EY · contact PI
MicroRNAs for therapy of visual disorders$2,085,203
R24 · FY2013 · EY · contact PI
Integrins and Ocular Angiogenesis$734,251
R01 · FY2013 · EY · contact PI
MicroRNAs for therapy of visual disorders$2,153,006
R24 · FY2012 · EY · contact PI
Integrins and Ocular Angiogenesis$780,895
R01 · FY2012 · EY · contact PI
Adult Stem Cells for Therapy of Visual Disorders$3,769,555
R24 · FY2011 · EY · contact PI
Adult Stem Cells for Therapy of Visual Disorders$3,538,648
R24 · FY2010 · EY · contact PI
Integrins and Ocular Angiogenesis$215,000
R01 · FY2010 · EY · contact PI
Adult Stem Cells for Therapy of Visual Disorders$120,280
R24 · FY2010 · EY · contact PI
Adult Stem Cells for Therapy of Visual Disorders$3,441,228
R24 · FY2009 · EY · contact PI
Integrins and Ocular Angiogenesis$974,701
R01 · FY2009 · EY · contact PI
Integrins and Ocular Angiogenesis$142,125
R01 · FY2009 · EY · contact PI
Adult Stem Cells for Therapy of Visual Disorders$3,346,543
R24 · FY2008 · EY · contact PI
Integrins and Ocular Angiogenesis$934,887
R01 · FY2008 · EY · contact PI
Adult Stem Cells for Therapy of Visual Disorders$3,299,060
R24 · FY2007 · EY · contact PI
Integrins and Ocular Angiogenesis$916,089
R01 · FY2007 · EY · contact PI
Integrins and Ocular Angiogenesis$173,000
R01 · FY2007 · EY · contact PI
Fragments of TrpRS to Treat Neovascular Eye Diseases$2,022,588
R24 · FY2006 · EY · contact PI
Integrins and Ocular Angiogenesis$896,068
R01 · FY2006 · EY · contact PI
Fragments of TrpRS to Treat Neovascular Eye Diseases$1,965,931
R24 · FY2005 · EY
Integrins and Ocular Angiogenesis$890,905
R01 · FY2005 · EY
Core Grant for Vision Research$522,844
P30 · FY2005 · EY
Fragments of TrpRS to Treat Neovascular Eye Diseases$1,910,921
R24 · FY2004 · EY
Core Grant for Vision Research$522,844
P30 · FY2004 · EY
INTEGRINS AND OCULAR ANGIOGENESIS$454,760
R01 · FY2004 · EY
Fragments of TrpRS to Treat Neovascular Eye Diseases$1,930,367
R24 · FY2003 · EY
Core Grant for Vision Research$1,381,610
P30 · FY2003 · EY
INTEGRINS AND OCULAR ANGIOGENESIS$536,515
R01 · FY2003 · EY
Fragments of TrpRS to Treat Neovascular Eye Diseases$1,789,537
R24 · FY2002 · EY
Core Grant for Vision Research$501,683
P30 · FY2002 · EY
INTEGRINS AND OCULAR ANGIOGENESIS$444,241
R01 · FY2002 · EY
Fragments of TrpRS to Treat Neovascular Eye Diseases$432,546
R24 · FY2002 · EY
Core--Microarrays$0
P30 · FY2002 · EY
Core Grant for Vision Research$626,299
P30 · FY2001 · EY
INTEGRINS AND OCULAR ANGIOGENESIS$503,617
R01 · FY2001 · EY
Core--Microarrays$0
P30 · FY2001 · EY
INTEGRINS AND OCULAR ANGIOGENESIS$453,812
R01 · FY2000 · EY
INTEGRINS AND OCULAR ANGIOGENESIS$233,561
R01 · FY2000 · EY
CELL BASED OCULAR DELIVERY OF ANTIANGIOGENICS FOR PDR$231,287
R01 · FY2000 · EY